Barinthus Biotherapeutics PLC BRNS
0.74 USD -0.02 (-2.49%)
At closeSep 8, 2026, 4:00 PM EDT
0.74 0.00 -0.57%
After hours · Sep 8, 4:00 PM ET
0.6421 Day range 0.7629
0.801 52-week range 4.16
- YTD
- +5.73%
- 1 year
- -19.82%
Analyst view
Price target (mean) 7.25 +879.6% upside
Now 0.7401
- Target (low)
- 5.00
- Target (mean)
- 7.25
- Target (high)
- 9.50
Ratings (0m) 3 3 buy · 0 hold · 0 sell
- Strong buy1
- Buy2
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 4
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.41 | -0.42 – -0.40 | -0.45 | +8.9% | 0 | 0.0% | 3 |
| Next quarter | -0.44667 | -0.55 – -0.37 | -0.40 | -11.7% | 0 | 0.0% | 3 |
| Current year | -1.56 | -1.67 – -1.44 | -1.91 | +18.6% | 9.99M | +1145.6% | 3 |
| Next year | -1.80 | -2.17 – -1.52 | -1.56 | -15.5% | 0 | -100.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 8, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 1, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 26, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 13, 2024 | Alliance Global Partners | Maintained | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 13, 2024 | Barclays | Maintained | — | Overweight |
| Jun 7, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 22, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 19, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Mar 21, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 28, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Sep 25, 2023 | Alliance Global Partners | Initiated | — | Buy |
| Sep 25, 2023 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Aug 18, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 13, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 16, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Mar 29, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 27, 2023 | HC Wainwright & Co. | Maintained | — | Buy |
| Mar 21, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Aug 15, 2022 | Morgan Stanley | Maintained | — | Overweight |
| Aug 11, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| May 17, 2022 | Morgan Stanley | Maintained | — | Overweight |
| May 13, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Dec 15, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| May 25, 2021 | William Blair | Initiated | — | Outperform |
| May 25, 2021 | Jefferies | Initiated | — | Buy |
| May 25, 2021 | Morgan Stanley | Initiated | — | Overweight |
| May 24, 2021 | HC Wainwright & Co. | Initiated | — | Buy |